Literature DB >> 24001739

The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.

Rasha Al-Saaidi1, Torsten B Rasmussen, Johan Palmfeldt, Peter H Nissen, Abdelaziz Beqqali, Jakob Hansen, Yigal M Pinto, Thomas Boesen, Jens Mogensen, Peter Bross.   

Abstract

Dilated cardiomyopathy (DCM) is a disease of the heart muscle characterized by cardiac chamber enlargement and reduced systolic function of the left ventricle. Mutations in the LMNA gene represent the most frequent known genetic cause of DCM associated with disease of the conduction systems. The LMNA gene generates two major transcripts encoding the nuclear lamina major components lamin A and lamin C by alternative splicing. Both haploinsuffiency and dominant negative effects have been proposed as disease mechanism for premature termination codon (PTC) mutations in LMNA. These mechanisms however are still not clearly established. In this study, we used a representative LMNA nonsense mutation, p.Arg321Ter, to shed light on the molecular disease mechanisms. Cultured fibroblasts from three DCM patients carrying this mutation were analyzed. Quantitative reverse transcriptase PCR and sequencing of these PCR products indicated that transcripts from the mutant allele were degraded by the nonsense-mediated mRNA decay (NMD) mechanism. The fact that no truncated mutant protein was detectable in western blot (WB) analysis strengthens the notion that the mutant transcript is efficiently degraded. Furthermore, WB analysis showed that the expression of lamin C protein was reduced by the expected approximately 50%. Clearly decreased lamin A and lamin C levels were also observed by immunofluorescence microscopy analysis. However, results from both WB and nano-liquid chromatography/mass spectrometry demonstrated that the levels of lamin A protein were more reduced suggesting an effect on expression of lamin A from the wild type allele. PCR analysis of the ratio of lamin A to lamin C transcripts showed unchanged relative amounts of lamin A transcript suggesting that the effect on the wild type allele was operative at the protein level. Immunofluorescence microscopy analysis showed no abnormal nuclear morphology of patient fibroblast cells. Based on these data, we propose that heterozygosity for the nonsense mutation causes NMD degradation of the mutant transcripts blocking expression of the truncated mutant protein and an additional trans effect on lamin A protein levels expressed from the wild type allele. We discuss the possibility that skewing of the lamin A to lamin C ratio may contribute to ensuing processes that destabilize cardiomyocytes and trigger cardiomyopathy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dilated cardiomyopathy; Haploinsufficiency; LMNA; Laminopathies; Nonsense mediated mRNA decay; Premature termination codon mutation

Mesh:

Substances:

Year:  2013        PMID: 24001739     DOI: 10.1016/j.yexcr.2013.08.024

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  9 in total

1.  Proteomic profiling of cardiac tissue by isolation of nuclei tagged in specific cell types (INTACT).

Authors:  Nirav M Amin; Todd M Greco; Lauren M Kuchenbrod; Maggie M Rigney; Mei-I Chung; John B Wallingford; Ileana M Cristea; Frank L Conlon
Journal:  Development       Date:  2014-02       Impact factor: 6.868

Review 2.  Do lamin A and lamin C have unique roles?

Authors:  Rasha Al-Saaidi; Peter Bross
Journal:  Chromosoma       Date:  2014-10-07       Impact factor: 4.316

3.  Diagnostic Yield of Genetic Testing in Young Patients With Atrioventricular Block of Unknown Cause.

Authors:  Johnni Resdal Dyssekilde; Tanja Charlotte Frederiksen; Morten Krogh Christiansen; Rikke Hasle Sørensen; Lisbeth Nørum Pedersen; Peter Loof Møller; Lene Svendstrup Christensen; Jacob Moesgaard Larsen; Kristian Korsgaard Thomsen; Tommi Bo Lindhardt; Morten Böttcher; Stig Molsted; Ole Havndrup; Thomas Fischer; Dorthe Svenstrup Møller; Finn Lund Henriksen; Jens Brock Johansen; Jens Cosedis Nielsen; Henning Bundgaard; Mette Nygaard; Henrik Kjærulf Jensen
Journal:  J Am Heart Assoc       Date:  2022-04-26       Impact factor: 6.106

4.  The effect of the lamin A and its mutants on nuclear structure, cell proliferation, protein stability, and mobility in embryonic cells.

Authors:  Katarzyna Piekarowicz; Magdalena Machowska; Ewelina Dratkiewicz; Daria Lorek; Agnieszka Madej-Pilarczyk; Ryszard Rzepecki
Journal:  Chromosoma       Date:  2016-08-17       Impact factor: 4.316

5.  Gene expression profiling of fibroblasts in a family with LMNA-related cardiomyopathy reveals molecular pathways implicated in disease pathogenesis.

Authors:  Halida P Widyastuti; Trina M Norden-Krichmar; Anna Grosberg; Michael V Zaragoza
Journal:  BMC Med Genet       Date:  2020-07-22       Impact factor: 2.023

Review 6.  Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies.

Authors:  Kristien Peeters; Teodora Chamova; Albena Jordanova
Journal:  Brain       Date:  2014-06-25       Impact factor: 13.501

7.  Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.

Authors:  Michael V Zaragoza; Lianna Fung; Ember Jensen; Frances Oh; Katherine Cung; Linda A McCarthy; Christine K Tran; Van Hoang; Simin A Hakim; Anna Grosberg
Journal:  PLoS One       Date:  2016-05-16       Impact factor: 3.240

8.  The expression of Lamin A mutant R321X leads to endoplasmic reticulum stress with aberrant Ca2+ handling.

Authors:  Monica Carmosino; Andrea Gerbino; Giorgia Schena; Giuseppe Procino; Rocchina Miglionico; Cinzia Forleo; Stefano Favale; Maria Svelto
Journal:  J Cell Mol Med       Date:  2016-07-15       Impact factor: 5.310

9.  Engineered pegRNAs improve prime editing efficiency.

Authors:  James W Nelson; Peyton B Randolph; Simon P Shen; Kelcee A Everette; Peter J Chen; Andrew V Anzalone; Meirui An; Gregory A Newby; Jonathan C Chen; Alvin Hsu; David R Liu
Journal:  Nat Biotechnol       Date:  2021-10-04       Impact factor: 68.164

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.